A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 18, Issue 3, 2004, Pages 587-588

  Iwanaga, Yoshitaka ^a   Gu, Yusu ^a   Dieterle, Thomas ^a   Presotto, Cristina ^a   Del Soldato, Piero ^a   Peterson, Kirk L ^a   Ongini, Ennio ^a   Condorelli, Gianluigi ^a   Ross Jr , John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; CYTOSKELETON PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; ENALAPRIL; ENZYME INHIBITOR; MEMBRANE PROTEIN; NCX 899; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; SARCOGLYCAN;

ANIMAL; AORTA; ARTICLE; BLOOD; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; ECHOGRAPHY; GENETICS; HAMSTER; HEART CONTRACTION; HEART VENTRICLE REMODELING; HEMODYNAMICS; MALE; METABOLISM; RABBIT; SYRIAN HAMSTER; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; CARDIOMYOPATHY, DILATED; CRICETINAE; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; ENALAPRIL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; MALE; MEMBRANE GLYCOPROTEINS; MESOCRICETUS; MYOCARDIAL CONTRACTION; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRITES; OXADIAZOLES; QUINOXALINES; RABBITS; SARCOGLYCANS; VASOCONSTRICTION; VENTRICULAR REMODELING;

MLCS; MLOWN;

EID: 2442640601     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.03-0872fje     Document Type: Article

References (0)